H225D (p.His225Asp) variant of GLA (Alpha-galactosidase A)
H225D (p.His225Asp) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.62 / 1. The record also includes published literature and structural context.
H225D (p.His225Asp) variant details
- p.His225Asp
- rs1928196686
- ClinGen CA413924951
- ClinVar RCV001216323
- Ensembl rs1928196686
- Likely pathogenic
- Fabry disease
- Missense
- Variant Prioritization Score for Impact Estimate 0.622
- AlphaMissense 0.16
- MetaLR 0.97
- MetaSVM 1.25
- PolyPhen-2 0.07
- SIFT 0.20
- EVE 0.20
- ClinVar: Likely pathogenic (Fabry disease)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Structural context available
- Cited in: Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (PMID 12735292)
- Cited in: Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. (PMID 16980809)